Shannon Weaver
Physician Assistant · Reno, NVNPI 1457903791
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 97.4% of the total across 396 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 43 manufacturers, the largest accounting for just 15.2% — the pattern of someone who eats at a lot of different presentations. Among physician assistant clinicians in NV with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 396 payments — averaging $18.66 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- Astellas Pharma US Inc$715
- GSK$487
- Pfizer$482
- AstraZeneca$457
- Amgen$338
- plus $4K from 37 others
What the payments were for
- Food & beverage$7,19697%
- Education$1933%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- AREXVY$122
How this compares
$7,389 in reported general payments places this provider in the 90th percentile of 881 physician assistant providers in Nevada.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 62 | $104,621 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 59 | $79,560 |
| Humira(Cf) PenAdalimumab | 12 | $78,058 |
| ForteoTeriparatide | 13 | $60,280 |
| JardianceEmpagliflozin | 27 | $44,654 |
| EliquisApixaban | 42 | $44,046 |
| JanuviaSitagliptin Phosphate | 23 | $31,961 |
| XareltoRivaroxaban | 23 | $23,483 |
| FarxigaDapagliflozin Propanediol | 17 | $20,001 |
| TradjentaLinagliptin | 14 | $19,449 |
| Anoro ElliptaUmeclidinium Brm/Vilanterol Tr | 11 | $14,091 |
| MyrbetriqMirabegron | 12 | $11,608 |
| Arnuity ElliptaFluticasone Furoate | 22 | $11,300 |
| Breo ElliptaFluticasone/Vilanterol | 14 | $9,431 |
| EntrestoSacubitril/Valsartan | 12 | $7,932 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| GSKTrelegy Ellipta, Anoro Ellipta, Arnuity Ellipta, Breo Ellipta | $487 | $114,383106 claims |
| Novo NordiskOzempic | $288 | $104,62162 claims |
| Boehringer IngelheimJardiance, Tradjenta | $321 | $64,10341 claims |
| Lilly USA, LLCForteo | $248 | $60,28013 claims |
| PfizerEliquis | $482 | $44,04642 claims |
| MerckJanuvia | $214 | $31,96123 claims |
| Johnson & JohnsonXarelto | $327 | $23,48323 claims |
| AstraZenecaFarxiga | $457 | $20,00117 claims |
| Astellas Pharma US IncMyrbetriq, Veozah | $715 | $18,48723 claims |
| NovartisEntresto | $113 | $7,93212 claims |
| AbbVieSynthroid | $1,124 | $2,14026 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 881 physician assistant providers in Nevada.
Other physician assistant in Reno
- John LarsenReno$49K
- Laura BiehleReno$36K
- Benjamin ProhaskaReno$31K
- Rebecca SparksReno$16K
- Daniel CollReno$12K
- Cameron WheelerReno$11K
- Julia WronaReno$10K
- Amber FrancoReno$9K
- Paul JohnsReno$8K
- Leila NazparvarReno$7K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.